7 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Terminated 7 |
Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan) Implantable Hemodynamic Monitor, Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Type 1 Receptor Blocker - Congestive Heart Failure | Phase 4 | Terminated | Brigham and Women's Hospital | 4 | 2016-09-01 | 2020-02-17 |
| Catheter Ablation vs. Medical Therapy in Congested Hearts With AF Catheter Ablation, FDA approved anti arrhythmic drug - Congestive Heart Failure, Left Ventricular Failure | Phase 4 | Terminated | The Cleveland Clinic | 4 | 2016-06-01 | 2025-06-05 |
| Nesiritide and Renal Function After the Total Artificial Heart nesiritide, placebo - Congestive Heart Failure, Cardiorenal Syndrome | Phase 4 | Terminated | Virginia Commonwealth University | 2 | 2013-04-01 | 2016-02-08 |
| Cardiac Resynchronization Therapy, Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure (CHF) Active Cardiac Resynchronization Therapy (CRT) - Congestive Heart Failure | Phase 4 | Terminated | Queen's University | 2 | 2008-10-01 | 2011-07-06 |
| BNP Therapy Observation Unit Outcomes STudy (BOOST) Nesiritide - Congestive Heart Failure | Phase 4 | Terminated | Emory University | 17 | 2007-03-01 | 2015-02-09 |
| BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) Beta blocker (carvedilol or metoprolol succinate), CRT (cardiac resynchronization therapy) - Congestive Heart Failure | Phase 4 | Terminated | St. Luke's-Roosevelt Hospital Center | 2 | 2007-01-01 | 2015-10-30 |
| Use of Nesiritide in the Management of Acute Diastolic Heart Failure Nesiritide - Heart Failure, Cardiovascular Disease | Phase 4 | Terminated | M.D. Anderson Cancer Center | 9 | 2004-05-17 | 2018-11-07 |
Heart Failure (7) · Dyspnea (2) · Atrial Fibrillation (1) · Cardio-Renal Syndrome (1) · Cardiovascular Diseases (1) · Edema (1) · Fatigue (1) · Heart Diseases (1) · Heart Failure, Diastolic (1)
Cardiovascular Diseases (6) · Heart Diseases (6) · Pathological Conditions, Signs and Symptoms (3) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Arrhythmias, Cardiac (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Renal Insufficiency (1) · Urogenital Diseases (1)
Natriuretic Peptide, Brain (3) · Adrenergic beta-Antagonists (1) · Angiotensin II Type 1 Receptor Blockers (1) · Angiotensin Receptor Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Cardiac Resynchronization Therapy (1) · Carvedilol (1) · Catheter Ablation (1) · Metoprolol (1) · sacubitril and valsartan sodium hydrate drug combination (1)
Brigham and Women's Hospital (1) · Emory University (1) · M.D. Anderson Cancer Center (1) · Queen's University (1) · St. Luke's-Roosevelt Hospital Center (1) · The Cleveland Clinic (1) · Virginia Commonwealth University (1)
United States (5) · Canada (1)
Chris M. Parker, MD, MSc (1) · Daniel Wu, MD (1) · Douglas Ander, MD (1) · Jean-Bernard Durand, MD (1) · Keyur B. Shah, MD (1) · Lauren G Gilstrap, MD (1) · Marrick L Kukin, MD (1) · Oussama Wazni, MD (1)